Bioverativ Inc (BIVV)

Currency in USD
104.98
0.00(0.00%)
Closed·
Showing Bioverativ historical data. For real-time data please try another search
Day's Range
104.97105.01
52 wk Range
0.00105.01
Key Statistics
Prev. Close
104.65
Open
104.97
Day's Range
104.97-105.01
52 wk Range
0-0
Volume
-
Average Volume (3m)
2.18M
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Bioverativ Inc Company Profile

Bioverativ Inc. is a biopharmaceutical company that engages in the development of therapies and programs for hemophilia, cold agglutinin disease, sickle cell disease, beta thalassemia, and other blood disorders. Its pipeline includes hemophilia programs that provide less-frequent prophylactic dosing for hemophilia A and subcutaneous dosing for hemophilia B; and gene therapy programs for hemophilia A and B. The company also includes programs to address cold agglutinin disease, a rare and chronic autoimmune hemolytic condition; and Sutimlimab (formerly BIVV009), a therapy in development that is designed to selectively inhibit the complement pathway of the immune system. Bioverativ Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts. Bioverativ Inc. operates as a subsidiary of Sanofi.

Earnings

Latest Release
Feb 13, 2019
EPS / Forecast
-- / 1.09
Revenue / Forecast
-- / 361.88M
EPS Revisions
Last 90 days

BIVV Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.